OSE Pharma (France) Analysis
| OSE Stock | EUR 8.68 0.03 0.35% |
OSE Pharma SA is overvalued with Real Value of 7.27 and Hype Value of 8.65. The main objective of OSE Pharma stock analysis is to determine its intrinsic value, which is an estimate of what OSE Pharma SA is worth, separate from its market price. There are two main types of OSE Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect OSE Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of OSE Pharma's stock to identify patterns and trends that may indicate its future price movements.
The OSE Pharma stock is traded in France on Euronext Paris, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in France. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and OSE Pharma's ongoing operational relationships across important fundamental and technical indicators.
OSE |
OSE Stock Analysis Notes
About 39.0% of the company outstanding shares are owned by corporate insiders. The book value of OSE Pharma was now reported as 2.53. The company recorded a loss per share of 0.41. OSE Pharma SA had not issued any dividends in recent years. OSE Immunotherapeutics SA, a biotechnology company, focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. OSE Immunotherapeutics SA is headquartered in Nantes, France. OSE IMMUNO operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 34 people. To find out more about OSE Pharma SA contact the company at 33 2 28 29 10 10 or learn more at https://www.ose-immuno.com.OSE Pharma SA Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. OSE Pharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding OSE Pharma SA or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| OSE Pharma SA had very high historical volatility over the last 90 days | |
| The company reported the revenue of 26.31 M. Net Loss for the year was (16.85 M) with profit before overhead, payroll, taxes, and interest of 26.31 M. | |
| OSE Pharma SA has accumulated about 33.58 M in cash with (9.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84. | |
| Roughly 39.0% of the company outstanding shares are owned by corporate insiders |
OSE Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 104.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OSE Pharma's market, we take the total number of its shares issued and multiply it by OSE Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.OSE Profitablity
OSE Pharma's profitability indicators refer to fundamental financial ratios that showcase OSE Pharma's ability to generate income relative to its revenue or operating costs. If, let's say, OSE Pharma is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, OSE Pharma's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of OSE Pharma's profitability requires more research than a typical breakdown of OSE Pharma's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.22) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.25) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.25. Technical Drivers
As of the 22nd of November, OSE Pharma holds the Mean Deviation of 3.16, risk adjusted performance of 0.0645, and Semi Deviation of 3.95. Concerning fundamental indicators, the technical analysis model allows you to check practical technical drivers of OSE Pharma, as well as the relationship between them.OSE Pharma SA Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. OSE Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for OSE Pharma SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
OSE Pharma Outstanding Bonds
OSE Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. OSE Pharma SA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most OSE bonds can be classified according to their maturity, which is the date when OSE Pharma SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
OSE Pharma Predictive Daily Indicators
OSE Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OSE Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
OSE Pharma Forecast Models
OSE Pharma's time-series forecasting models are one of many OSE Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary OSE Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About OSE Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how OSE Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling OSE shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as OSE Pharma. By using and applying OSE Stock analysis, traders can create a robust methodology for identifying OSE entry and exit points for their positions.
OSE Immunotherapeutics SA, a biotechnology company, focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. OSE Immunotherapeutics SA is headquartered in Nantes, France. OSE IMMUNO operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 34 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding OSE Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Complementary Tools for OSE Stock analysis
When running OSE Pharma's price analysis, check to measure OSE Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OSE Pharma is operating at the current time. Most of OSE Pharma's value examination focuses on studying past and present price action to predict the probability of OSE Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OSE Pharma's price. Additionally, you may evaluate how the addition of OSE Pharma to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |